TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/9/22 15:24 | 3/7/22 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grassman Catherine | CO | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 7 | 10 | D | ||||||||||||||
8/9/21 16:20 | 8/6/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grassman Catherine | CO | O | EVP,CFO | M.d | 349 | 69.77 | 0 | 5 | 4 | D | |||||||||||||||
8/9/21 16:20 | 8/6/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grassman Catherine | CO | O | EVP,CFO | S.d | -1,301 | 260.24 | 0 | -5 | -56 | 4 | D | ||||||||||||||
3/9/21 12:28 | 3/7/21 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grassman Catherine | CO | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 18 | 4 | D | ||||||||||||||
3/10/20 15:03 | 3/7/20 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grassman Catherine | CO | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 1 | 29 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |